Inside Vladimir Putin’s Longevity Obsession and Russia’s 7,000-Monkey Experiment
In the autumn of 2025, a hot microphone at a military parade in Beijing captured a candid exchange between two of the world’s most powerful autocrats. Walking alongside Chinese President Xi Jinping, Russian President Vladimir Putin—then approaching his seventy-third birthday—remarked on the boundless potential of modern biotechnology. “With biotech, organs can be replaced endlessly,” Putin said through his interpreter, adding that humanity “could even reach immortality”. Xi nodded along, noting that while people once rarely lived past seventy, some scientists now predict human lifespans could stretch to 150 years within this century. Months later, at an artificial intelligence conference in Moscow, Putin reiterated that exact number publicly, musing that extending human life to 150 was an achievable frontier.
For a leader who turned 74 in October 2026 and has ruled Russia for more than a quarter-century, extending the biological clock is far more than idle philosophical speculation. Over the past two years, the Kremlin has transformed life extension from a fringe scientific curiosity into a heavily funded state priority. At the center of this ambitious, secretive push is a massive primate research initiative housing more than 7,000 monkeys, alongside a newly established primate blood biobank, 3D organ bioprinting programs, and a tight-knit circle of Kremlin loyalists and family members steering billions of rubles toward cracking the code of human aging.
The Kurchatov Institute and the Primate Colony
In November 2026, the scale of Russia’s biological quest came into sharper focus during the Kurchatov Genomic Forum in Moscow. Speaking on the sidelines of the event, Mikhail Kovalchuk—a physicist, longtime confidant of Putin, and head of the National Research Center “Kurchatov Institute”—revealed that Russian scientists are systematically screening elderly primates to map every stage of the aging process.
Kovalchuk, whose brother Yuri is a sanctioned billionaire banker often described as Putin’s personal cashier, serves as the Russian president’s informal chief adviser on genetics and state science. Under Kovalchuk’s direction, the Kurchatov Institute’s breeding facilities and nurseries house a colony of more than 7,000 monkeys spanning 22 different species. Among them is what Kovalchuk described as a unique cohort of geriatric primates aged between 18 and more than 30 years old—an advanced age for non-human primates.
“We are now screening elderly monkeys to look at all stages of aging,” Kovalchuk told reporters, explaining that researchers are subjecting the animals to comprehensive biochemical and structural analyses, closely examining their brains, cardiovascular systems, and blood vessels. Because non-human primates share close physiological and genetic similarities with humans, Kovalchuk argued that studying how their bodies deteriorate—or resist deterioration—provides “the basis for creating a regulatory system for extending” the human lifespan.
To accelerate this research, the Kurchatov Institute has partnered with the Petrovsky Russian Research Center of Surgery to establish a specialized biobank of blood samples drawn from long-lived primates. According to Konstantin Kotenko, director of the surgery center, scientists are analyzing these samples to isolate the cellular and molecular mechanisms that govern senescence, searching for biomarkers or blood-borne factors that could eventually be harnessed to slow down human aging.
A State-Backed “Elixir of Youth”
The primate blood bank is only one pillar of a sprawling, state-directed longevity apparatus. Following directives from the Kremlin, the Russian government launched a national initiative dubbed “New Health Preservation Technologies,” earmarking substantial state funds to turn anti-aging theory into clinical reality. According to budget projections for 2027 through 2029, Moscow plans to pour nearly 18 billion rubles (roughly $216 million to $217 million) directly into this program, with dedicated streams for preventive medicine, cellular senescence research, and regenerative therapies.
The scientific roadmap extends well beyond blood analysis. Russian researchers are actively pursuing gene therapies designed to halt cellular decay, alongside radical approaches to organ replacement. These include 3D bioprinting of living human tissues and xenotransplantation—specifically, cultivating genetically modified miniature pigs to grow replacement organs compatible with the human body.
Crucially, this scientific empire is kept strictly within the family. Putin’s eldest daughter, Maria Vorontsova, a trained pediatric endocrinologist, plays a prominent public and institutional role in Russia’s genetic and longevity research. In October 2026, Vorontsova appeared at the Moscow School of Management Skolkovo to help inaugurate a new longevity laboratory. While she has previously suggested that Russia has a chance to lead the world in developing anti-aging pharmaceuticals, she also struck a surprisingly philosophical note at the Skolkovo opening, describing humanity’s effort to push past its natural biological limits as an attempt to “deceive God”.
Political Obsession vs. Scientific Reality
Independent Russian journalists and Western analysts view the Kremlin’s sudden embrace of gerontology not as a public health initiative, but as an extension of personal and political self-preservation. Investigative outlets such as Meduza and Agentstvo have reported that the state anti-aging push was born out of “an obsession amplified by lobbying” from figures like Kovalchuk, who have successfully pitched biological immortality to an aging ruler.
The irony has not been lost on observers. Even as the Kremlin pours millions into preserving the lives of its aging elite and studying geriatric monkeys in Moscow labs, Russia’s ongoing war in Ukraine has claimed hundreds of thousands of young Russian lives, driving down the country’s overall male life expectancy. For the average Russian citizen, living to 75 remains a statistical hurdle; living to 150 is pure science fiction.
Furthermore, mainstream biogerontologists outside Russia remain deeply skeptical of claims that humanity is on the verge of a 150-year lifespan. While primate studies—such as the famous decades-long caloric restriction trials conducted in the United States—have yielded valuable insights into age-related diseases, translating primate biomarkers into a safe, effective human “elixir of youth” remains extraordinarily complex. Organ bioprinting and xenotransplantation are still in their infancy, fraught with risks of immune rejection and systemic failure.
Yet inside the Kremlin, the quest continues unabated. In an autocracy where power is entirely personalized and succession carries existential risks, time is the one adversary Vladimir Putin cannot imprison, exile, or outmaneuver. Through 7,000 monkeys, vials of primate blood, and billions of state rubles, Russia’s scientific establishment is now tasked with solving the ultimate political problem: keeping its leader alive.
About The Author
